A swift rise in interest rates has been a notable headwind, pushing down share prices across the sector. Two stocks that are getting beaten down but that are still worth a very close look are Toronto-Dominion Bank (NYSE: TD), or TD Bank, and Bank of Nova Scotia (NYSE: BNS), or Scotiabank. Canada, the country from which TD Bank and Scotiabank both hail, has a highly regulated bank sector.
Q4 2024 SelectQuote Inc Earnings Call
Hope Caitlin warns many people can be left feeling "invisible" by workplace issues.
Large plumes of smoke are seen rising from the site, where 12 crews have been tackling a large fire.
Ormiston Academies Trust is removing access to phones for 35,000 pupils at its 42 schools.
The BBC favourite has been embroiled in scandal ahead of its big return to screens for its 20th anniversary
The Salford-born comedian wants local schoolchildren to have the chance to play the emerging sport.
Ukraine has repeatedly urged the UK and US to let it fire long-range missiles against targets inside Russia.
The council’s children’s services committee hears it is having to turn to the independent sector.
The council announces the brief closure of some roads in Wolverhampton for repair work.
The Prime Minister met with US President Joe Biden in Washington.
Kite fanatics from across the world descend on a seaside town for its annual festival.
Former president followed rambling Los Angeles press conference with Nevada rally
Carrie Maxfield was celebrated at BBC Radio Nottingham's Make a Difference Awards.
The Durham County Council report looks at the effect of stopping free afternoon parking.
The UK and US are believed to be on the cusp of allowing Kyiv to use long-range missiles inside Russia
The GOP nominee shared a conspiracy theory also backed by Laura Loomer.
- Clinically meaningful objective response rate (ORR) of 63.3-76.7% observed with belrestotug + dostarlimab combinations, with confirmed ORR (cORR) at ~60% for every dose- >30% cORR difference between belrestotug + dostarlimab vs dostarlimab monotherapy- Belrestotug + dostarlimab safety profile broadly consistent with known safety profile of checkpoint inhibitor combinations- GALAXIES Lung-301, global Phase 3 registration study, enrolling in same indication and setting- iTeos to host a conferenc
-- Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma of the Head and Neck Cohort -- -- No New Safety Signals or Added Systemic Safety Concerns Observed -- -- Data Presented at the European Society for Medical Oncology (ESMO) Congress -- NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therap
Duke of Sussex says becoming a father has given him new perspective on life
FirstRand ( JSE:FSR ) Full Year 2024 Results Key Financial Results Revenue: R127.0b (up 5.1% from FY 2023). Net income...
Yahoo Finance